- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study
December 21, 2017
Outcomes of Patients With Late-Relapse Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Single Institution Experience
December 21, 2017
Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database
December 21, 2017
Recurrence of renal cell cancer after renal transplantation in a multicenter French cohort
December 21, 2017
U.S. FDA Approves CABOMETYX® (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma
December 20, 2017
Sutent® (sunitinib malate) is FDA Approved as the First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma
December 20, 2017
FDA Approves Adjuvant Treatment for Adult Patients at a High Risk of Kidney Cancer Returning after Nephrectomy
December 20, 2017
Hospital Volume and Outcomes of Robot-Assisted Partial Nephrectomy
December 20, 2017
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma
December 19, 2017
Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma
December 18, 2017
Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland
December 18, 2017
Lymphatic drainage from renal tumors in vivo: a prospective sentinel node study using SPECT/CT imaging
December 15, 2017
Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
December 15, 2017
Robot-assisted Retrohepatic Inferior Vena Cava Thrombectomy: First or Second Porta Hepatis as an Important Boundary Landmark
December 15, 2017
Recurrent renal cancer in Birt-Hogg-Dubé syndrome: A case report.
December 14, 2017